GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr | ₹21 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹30 Cr |
Mar2022 | ₹24 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹21 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 36.57 | |
Mar2023 | ₹30 Cr | 21.91 | |
Mar2022 | ₹24 Cr | 27.25 | |
Mar2021 | ₹19 Cr | -8.79 | |
Mar2020 | ₹21 Cr | - |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹271.3 Cr | -4.9% | -10.8% | -35.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -4.9% |
-10.8% |
-35.9% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses